Principal Financial Group
TSVT

Principal Financial Group’s 2seventy bio TSVT Stock Holding History

Principal Financial Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,337
Closed -$76.7K – 2465
2024
Q1 		$76.7K Sell
14,337
-1,743
-11% -$8.2K ﹤0.01% 2302
2023
Q4 		$68.7K Sell
16,080
-191
-1% -$587 ﹤0.01% 2309
2023
Q3 		$63.8K Sell
16,271
-492
-3% -$3.23K ﹤0.01% 2333
2023
Q2 		$170K Buy
16,763
+4,471
+36% +$47.3K ﹤0.01% 2210
2023
Q1 		$125K Buy
12,292
+1,389
+13% +$15.9K ﹤0.01% 2265
2022
Q4 		$102K Buy
10,903
+614
+6% +$8.66K ﹤0.01% 2292
2022
Q3 		$149K Buy
+10,289
New +$153K ﹤0.01% 2260
2022
Q1 		– Sell
-77,240
Closed -$1.98M – 2600
2021
Q4 		$1.98M Buy
+77,240
New +$2.41M ﹤0.01% 1859

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Principal Financial Group's TSVT Position: Q2 2024 in Review

Principal Financial Group sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 14,337 shares — an estimated $76.7K sold.

Principal Financial Group first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $1.98M in Q4 2021. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • Principal Financial Group reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 14,337 2seventy bio shares in Q2 2024, an estimated $76.7K.
  • Principal Financial Group first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Principal Financial Group's 2seventy bio position peaked at $1.98M in Q4 2021.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.